{
  "docId": "019dd923-5de0-76bd-a164-b717ba6950ff",
  "docSlug": "eb4f894ec6f4abbf",
  "documentTitle": "Medical Affairs Outlook Report 2023",
  "authorId": "ZS",
  "authorName": "ZS",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 10,
  "pageCount": 17,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "Report page 9, ZS 2023.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bullet_list"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5de0-76bd-a164-b717ba6950ff/10",
  "deckHref": "/decks/019dd923-5de0-76bd-a164-b717ba6950ff",
  "deckJsonHref": "/decks/019dd923-5de0-76bd-a164-b717ba6950ff.json",
  "deckAnchorHref": "/decks/019dd923-5de0-76bd-a164-b717ba6950ff#slide-10",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Medical affairs continues to play an important role prior to a drug's launch, with more than 85% of external respondents saying they would like to begin scientific engagements with MSLs before launch.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-edaa-73b9-9029-a4e4e32bfb24",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.21,
        "y": 0.67
      },
      "kind": "list",
      "text": "The most important educational needs of KOLs change as products progress through their life cycles. Organizations should be cognizant of this and prioritize relevant information during their interactions with KOLs.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db3ddd9b-3f0b-452e-aded-8fe79d81435f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.6,
        "x": 0.21,
        "y": 0.73
      },
      "kind": "list",
      "text": "External respondents were asked to select one phase—from phase 1 through post launch—they would like to begin MSL engagements from, and to also specify information that they felt was most valuable in that particular phase. For each phase, nearly half of the",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e334a3e0-9821-4574-8586-c3a51332c49a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.21,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "As HEOR emerges as an important investment area for medical affairs organizations, companies are looking to enhance their integrated evidence planning (IEP) process. IEP helps organizations deliver a complete and differentiated evidence package that addresses the needs of external healthcare stakeholders beyond regulatory requirements. Almost a third of internal respondents ranked technology or tools that enhance knowledge management, collaborative plan development and evidence execution as the most important IEP investment.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c21547c-0047-4a2f-8641-8cca760492f1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.21,
        "y": 0.43
      },
      "kind": "paragraph",
      "text": "The dissemination of scientific information is an important step when establishing and maintaining the scientific share of voice among various pharma stakeholders. Medical affairs is a crucial function and should focus on providing the right information at the right time. Medical affairs organizations should also explore collaborating with KOLs and consider how to leverage digital solutions and social media to become more customer-centric.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0daaaf88-843f-4727-a6cf-8106a7b64778",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.21,
        "y": 0.58
      },
      "kind": "paragraph",
      "text": "Medical affairs continues to play an important role prior to a drug's launch, with more than 85% of external respondents saying they would like to begin scientific engagements with MSLs before launch. More than a third of the external respondents said they would prefer to begin engagements during phase 3 of clinical trials. Additional insights we gained from our analysis include:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cea4f398-e601-40f9-8168-9a870a58aa7c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.21,
        "y": 0.15
      },
      "kind": "title",
      "text": "Field medical continues to be the top area of investment, with the highest investments in additional full-time employees.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "08156262-b948-4250-8ec3-7168e7219d42",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.21,
        "y": 0.54
      },
      "kind": "title",
      "text": "Scientific engagements",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2581017d-0861-44cc-bbc7-69d11c15c0d4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.21,
        "y": 0.39
      },
      "kind": "title",
      "text": "Scientific market shaping",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5418289-0671-41f1-a419-a67c304bc134",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 15,
      "from": 9,
      "beatId": "c525a5ef-3a99-4c51-8abc-eb5dad661dff",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": "consultants-gambit-solution-approach",
      "evidence": "The deck provides key takeaways and recommendations for medical affairs organizations, including prioritizing investments and collaborating with external stakeholders",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    },
    {
      "to": 14,
      "from": 10,
      "beatId": "ddd73dd8-76c8-4866-b638-a1b59773307b",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The deck provides data and statistics to support its recommendations, including survey results from internal and external respondents",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 6,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "fb6f3987-81f5-48cc-b7d0-39a0cd21772e",
      "evidence": "The deck presents a logical chain of ideas, starting with the situation overview and building towards key takeaways and recommendations",
      "position": 0,
      "objective": "Understand the engagement landscape and prioritize investments",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 15,
      "from": 9,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "dff223a3-dda3-48f8-a5dd-27a7371e6fe5",
      "evidence": "The deck implies that not prioritizing investments and adapting to changing engagement landscapes may result in missed opportunities",
      "position": 1,
      "objective": "Highlight the consequences of not adapting to changing engagement landscapes",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}